Tag: AlphaVac
First patient enrolled in RECOVER-AV trial of AlphaVac F18 system for...
AngioDynamics has announced the first patient has been enrolled in the RECOVER-AV clinical trial, a prospective, multicentre, international, single-arm study evaluating the AlphaVac multipurpose...
APEX-AV trial results of AlphaVac PE system published in JSCAI
AngioDynamics has announced the publication of the results from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac system—APEX-AV—in the Journal of the Society...
AngioDynamics announces CE mark approval for AlphaVac system
AngioDynamics, a leading medical technology company focused on restoring healthy blood flow in the body’s vascular system, has announced European CE mark approval of...
